X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4807) 4807
Publication (298) 298
Book Review (61) 61
Book Chapter (25) 25
Newsletter (22) 22
Magazine Article (18) 18
Newspaper Article (5) 5
Conference Proceeding (4) 4
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3411) 3411
allopurinol - therapeutic use (2706) 2706
male (2411) 2411
allopurinol (2190) 2190
female (1649) 1649
index medicus (1527) 1527
middle aged (1236) 1236
animals (1197) 1197
adult (1097) 1097
gout - drug therapy (970) 970
uric acid - blood (956) 956
aged (885) 885
gout (853) 853
hyperuricemia (706) 706
gout suppressants - therapeutic use (676) 676
uric acid (562) 562
pharmacology & pharmacy (545) 545
rats (537) 537
allopurinol - pharmacology (517) 517
treatment outcome (468) 468
allopurinol - adverse effects (467) 467
rheumatology (443) 443
allopurinol - administration & dosage (418) 418
xanthine oxidase - antagonists & inhibitors (414) 414
surgery (409) 409
care and treatment (368) 368
febuxostat (360) 360
hyperuricemia - drug therapy (356) 356
adolescent (345) 345
transplantation (344) 344
management (331) 331
time factors (325) 325
risk factors (322) 322
medicine, general & internal (306) 306
immunology (304) 304
drug therapy, combination (297) 297
child (292) 292
uric acid - metabolism (274) 274
oxidative stress (267) 267
xanthine oxidase (247) 247
uric-acid (246) 246
analysis (243) 243
risk (242) 242
aged, 80 and over (240) 240
uric acid - urine (237) 237
colchicine - therapeutic use (235) 235
adenosine (231) 231
enzyme inhibitors - therapeutic use (228) 228
organ preservation solutions (226) 226
retrospective studies (226) 226
glutathione (223) 223
gout - blood (222) 222
dogs (220) 220
gout - complications (212) 212
arthritis (203) 203
medicine & public health (203) 203
insulin (199) 199
raffinose (199) 199
urology & nephrology (196) 196
gout suppressants - adverse effects (194) 194
oxidases (194) 194
follow-up studies (193) 193
gout - diagnosis (193) 193
therapy (192) 192
uricosuric agents - therapeutic use (192) 192
drug therapy (188) 188
serum uric-acid (184) 184
xanthine oxidase - metabolism (183) 183
dose-response relationship, drug (181) 181
xanthine-oxidase (181) 181
research (175) 175
cardiac & cardiovascular systems (173) 173
mice (166) 166
child, preschool (164) 164
double-blind method (163) 163
disease (160) 160
hypertension (160) 160
organ preservation - methods (160) 160
health aspects (158) 158
chronic disease (155) 155
rheumatism (150) 150
rats, wistar (149) 149
research article (145) 145
double-blind (144) 144
prospective studies (144) 144
acute disease (143) 143
xanthine (143) 143
efficacy (141) 141
rats, sprague-dawley (141) 141
patients (140) 140
mortality (139) 139
prevention (138) 138
disease models, animal (136) 136
ischemia (135) 135
free radicals (134) 134
urate (134) 134
oncology (133) 133
antiprotozoal agents - therapeutic use (132) 132
recurrence (132) 132
reperfusion injury - prevention & control (132) 132
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4279) 4279
German (197) 197
French (87) 87
Spanish (62) 62
Japanese (60) 60
Italian (52) 52
Russian (31) 31
Polish (24) 24
Chinese (11) 11
Hungarian (11) 11
Danish (9) 9
Czech (6) 6
Norwegian (6) 6
Dutch (5) 5
Hebrew (5) 5
Portuguese (5) 5
Swedish (4) 4
Bulgarian (2) 2
Croatian (2) 2
Finnish (2) 2
Serbian (2) 2
Korean (1) 1
Romanian (1) 1
Slovak (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2011, Volume 58, Issue 8, pp. 820 - 828
Objectives The aim of this study was to evaluate the effect of high-dose allopurinol on vascular oxidative stress (OS) and endothelial function in subjects... 
Cardiovascular | Internal Medicine | coronary artery disease | xanthine oxidase | vascular oxidative stress | allopurinol and endothelial dysfunction | OXIDATIVE STRESS | CARDIAC & CARDIOVASCULAR SYSTEMS | DEPENDENT VASODILATION | IMPROVES ENDOTHELIAL FUNCTION | INDUCED HEART-FAILURE | LOW-DENSITY-LIPOPROTEIN | ACUTE CORONARY SYNDROMES | XANTHINE-OXIDASE | BRACHIAL-ARTERY | IN-VITRO | DYSFUNCTION | F2-Isoprostanes - blood | Angina Pectoris - physiopathology | Humans | Endothelium, Vascular - drug effects | Male | Endothelium, Vascular - physiology | Dose-Response Relationship, Drug | Enzyme Inhibitors - administration & dosage | Brachial Artery - diagnostic imaging | Coronary Artery Disease - physiopathology | Ultrasonography | Female | Natriuretic Peptide, Brain - blood | Double-Blind Method | Angina Pectoris - drug therapy | Ascorbic Acid - administration & dosage | Cross-Over Studies | Allopurinol - administration & dosage | Antioxidants - administration & dosage | Aged | Coronary Artery Disease - epidemiology | Oxidative Stress - drug effects | Regional Blood Flow - physiology | Blood Flow Velocity - physiology | Lipoproteins, LDL - blood | Plethysmography | Oxidases | Low density lipoproteins | Allopurinol | Sodium nitroferricyanide | Cyanides | Angina pectoris | Endothelium | Purines | Molybdenum compounds | Nitric oxide | Dosage and administration | Acetylcholine | Health aspects | Usage | Studies | Heart attacks | Cardiology | Coronary vessels
Journal Article
Clinics in perinatology, ISSN 0095-5108, 2014, Volume 41, Issue 1, pp. 119 - 131
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2007, Volume 56, Issue 1, pp. 69 - 83
The widely accepted standard therapy for cutaneous sarcoidosis includes corticosteroids, antimalarials, and methotrexate. However, a better understanding of... 
Dermatology | TUMOR-NECROSIS-FACTOR | LOW-DOSE METHOTREXATE | ACTIVE PULMONARY SARCOIDOSIS | PULSED DYE-LASER | REFRACTORY SARCOIDOSIS | FACTOR-ALPHA PRODUCTION | LUPUS-PERNIO | TNF-ALPHA | HUMAN ALVEOLAR MACROPHAGES | BLOOD MONONUCLEAR-CELLS | DERMATOLOGY | Abnormalities, Drug-Induced - prevention & control | Chlorambucil - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Laser Therapy | Antibodies, Monoclonal - therapeutic use | Male | Dermatologic Agents - therapeutic use | Methotrexate - therapeutic use | Skin Diseases - pathology | Adrenal Cortex Hormones - therapeutic use | Th1 Cells - immunology | Pentoxifylline - therapeutic use | Contraindications | Infliximab | Sarcoidosis - immunology | Anti-Inflammatory Agents - therapeutic use | Female | Pentoxifylline - pharmacology | Drug Therapy, Combination | Th1 Cells - drug effects | Sarcoidosis - drug therapy | Skin Diseases - drug therapy | Skin Diseases - immunology | Antimalarials - therapeutic use | Sarcoidosis - etiology | Pregnancy Complications - drug therapy | Pregnancy | Skin Diseases - etiology | Cyclosporine - therapeutic use | Allopurinol - therapeutic use | Models, Immunological | Animals | Melatonin - therapeutic use | Antigen Presentation - drug effects | Cytokines - antagonists & inhibitors | Isoxazoles - therapeutic use | Thalidomide - therapeutic use | Tetracyclines - therapeutic use | Pregnancy Complications - immunology | Sarcoidosis - pathology
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 01/2017, Volume 166, Issue 1, pp. 58 - 68
Journal Article
Journal of Pediatrics, The, ISSN 0022-3476, 2012, Volume 160, Issue 4, pp. 544 - 552.e4
Journal Article
Seminars in Nephrology, ISSN 0270-9295, 2016, Volume 36, Issue 4, pp. 331 - 342
Summary Chronic kidney disease (CKD) is a common condition that has become a significant public health concern. The mainstay therapeutic approach to CKD is... 
Nephrology | progression | Chronic kidney disease | renin-angiotensin system | ANGIOTENSIN SYSTEM | CARDIOVASCULAR OUTCOMES | RENAL-FUNCTION | MICROVASCULAR OUTCOMES | DIABETIC-NEPHROPATHY | RECEPTOR ANTAGONIST | CONVERTING ENZYME-INHIBITION | DOUBLE-BLIND | UROLOGY & NEPHROLOGY | BLOOD-PRESSURE CONTROL | URIC-ACID | Bicarbonates - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Diabetic Nephropathies - drug therapy | Ergocalciferols - therapeutic use | Hypertension - drug therapy | Pentoxifylline - therapeutic use | Renal Insufficiency, Chronic - drug therapy | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Free Radical Scavengers - therapeutic use | Diabetic Nephropathies - prevention & control | Hypoglycemic Agents - therapeutic use | Vitamin B Complex - therapeutic use | Kidney Failure, Chronic - drug therapy | Diabetes Mellitus - drug therapy | Diabetes Mellitus - metabolism | Disease Progression | Hyperuricemia - drug therapy | Mineralocorticoid Receptor Antagonists - therapeutic use | Gout Suppressants - therapeutic use | Renal Insufficiency, Chronic - prevention & control | Allopurinol - therapeutic use | Kidney Failure, Chronic - prevention & control | Endothelin Receptor Antagonists - therapeutic use | Angiotensin Receptor Antagonists - therapeutic use | Pyridoxamine - therapeutic use
Journal Article